Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac in posterior thoracolumbar spinal fusions
NCT03278691Phase 4Recruiting
- Sponsor
- Henry Ford Health
- Start
- Oct 2017
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ketorolac in postoperative pain (2 arms), sponsored by Henry Ford Health. Primary endpoint: Fusion Construct X-Ray at 24 months. Started Oct 2017; status: recruiting.
02
Drugs
ketorolac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03278691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03278691.